4//SEC Filing
Pamir Ozan 4
Accession 0001834681-25-000005
CIK 0001386570other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 8:23 AM ET
Size
6.7 KB
Accession
0001834681-25-000005
Insider Transaction Report
Form 4
Pamir Ozan
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-11-14$6.81/sh+4,464.962$30,406→ 7,372.159 total - Purchase
Common Stock
2025-11-14$6.85/sh+2,220.443$15,210→ 2,220.443 total(indirect: By Spouse)
Footnotes (1)
- [F1]The weighted average purchase price for the transaction reported was $6.81, and the range of prices were between $6.7975 and $6.82, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided.
Documents
Issuer
Niagen Bioscience, Inc.
CIK 0001386570
Entity typeother
Related Parties
1- filerCIK 0001834681
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 8:23 AM ET
- Size
- 6.7 KB